Abstract
Feynman’s 1959 vision of a “smaller world” is now actively being realized through advances in nanotechnology and nanoscience [1]. Particularly over the past decade, nanotechnology has emerged as a nexus of physical and medical scientific research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feynman RP (1960) There’s plenty of room at the bottom. Eng Sci 23(5):22–36
National Science and Technology Council (2012) The national nanotechnology initiative—supplement to the president’s 2013 budget
National Institutes of Health Roadmap for Medical Research (2013) Nanomedicine http://commonfund.nih.gov/Nanomedicine/. Accessed 14 Oct 2013
Lammers T, Aime S, Hennink WE, Storm G, Kiessling F (2011) Theranostic nanomedicine. Acc Chem Res 44(10):1029–1038
Mendes RG, Bachmatiuk A, Buchner B, Cuniberti G, Rummeli MH (2013) Carbon nanostructures as multi-functional drug delivery platforms. J Mater Chem B 1(4):401–428
Kang SG, Zhou G, Yang P, Liu Y, Sun B et al (2012) Molecular mechanism of pancreatic tumor metastasis inhibition by gd@c82(oh)22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U.S.A. 109(38):15431–15436
Tu Y, Lv M, Xiu P, Huynh T, Zhang M et al (2013) Destructive extraction of phospholipids from escherichia coli membranes by graphene nanosheets. Nat Nanotechnol 8(8):594–601
Li H, Li Y, Jiao J, Hu HM (2011) Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol 6(10):645–650
Zhang Y, Zheng F, Yang T, Zhou W, Liu Y et al (2012) Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides. Nat Mater 11(9):817–826
Doane TL, Burda C (2012) The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 41(7):2885–2911
Yoo D, Lee JH, Shin TH, Cheon J (2011) Theranostic magnetic nanoparticles. Acc Chem Res 44(10):863–874
Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA et al (1998) Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of aids-related kaposi’s sarcoma: Results of a randomized phase iii clinical trial. J Clin Oncol Off J Am Soc Clin Oncol 16(7):2445–2451
Safra T, Muggia F, Jeffers S, Tsao-Wei DD, Groshen S et al (2000) Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol Off J Eur Soc Med Oncol/ESMO 11(8):1029–1033
Gradishar WJ (2006) Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7(8):1041–1053
Yoo J-W, Irvine DJ, Discher DE, Mitragotri S (2011) Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 10(7):521–535
Cabral H, Nishiyama N, Kataoka K (2011) Supramolecular nanodevices: from design validation to theranostic nanomedicine. Accounts Chem Res 44(10):999–1008
Lee PY, Wong KKY (2011) Nanomedicine: a new frontier in cancer therapeutics. Curr Drug Deliv 8(3):245–253
Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653–664
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387–6392
Maeda H, Matsumura Y (2011) Epr effect based drug design and clinical outlook for enhanced cancer chemotherapy. Adv Drug Deliv Rev 63(3):129–130
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257
Kaminski MS, Tuck M, Estes J, Kolstad A, Ross CW et al (2005) 131i-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 352(5):441–449
Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11):1649–1659
Jain RK, Lee JJ, Hong D, Markman M, Gong J et al (2010) Phase i oncology studies: Evidence that in the era of targeted therapies patients on lower doses do not fare worse. Clin Cancer Res Off J Am Assoc Cancer Res 16(4):1289–1297
Cha C, Shin SR, Annabi N, Dokmeci MR, Khademhosseini A (2013) Carbon-based nanomaterials: Multifunctional materials for biomedical engineering. ACS Nano 7(4):2891–2897
Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z et al (2007) Medicinal applications of fullerenes. Int J Nanomed 2(4):639–649
Anilkumar P, Lu F, Cao L, Luo PG, Liu JH et al (2011) Fullerenes for applications in biology and medicine. Curr Med Chem 18(14):2045–2059
Chawla P, Chawla V, Maheshwari R, Saraf SA, Saraf SK (2010) Fullerenes: from carbon to nanomedicine. Mini-Rev Med Chem 10(8):662–677
Cai X, Jia H, Liu Z, Hou B, Luo C et al (2008) Polyhydroxylated fullerene derivative c(60)(oh)(24) prevents mitochondrial dysfunction and oxidative damage in an mpp(+)-induced cellular model of parkinson’s disease. J Neurosci Res 86(16):3622–3634
Bogdanovic V, Stankov K, Icevic I, Zikic D, Nikolic A et al (2008) Fullerenol c60(oh)24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line. J Radiat Res 49(3):321–327
Ashcroft JM, Tsyboulski DA, Hartman KB, Zakharian TY, Marks JW et al (2006) Fullerene (c60) immunoconjugates: interaction of water-soluble c60 derivatives with the murine anti-gp240 melanoma antibody. Chem Commun (Camb) 28:3004–3006
Lu X, Feng L, Akasaka T, Nagase S (2012) Current status and future developments of endohedral metallofullerenes. Chem Soc Rev 41(23):7723–7760
Kato H, Kanazawa Y, Okumura M, Taninaka A, Yokawa T et al (2003) Lanthanoid endohedral metallofullerenols for mri contrast agents. J Am Chem Soc 125(14):4391–4397
Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y et al (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for mri contrast agents. Bioconjug Chem 12(4):510–514
Chen C, Xing G, Wang J, Zhao Y, Li B et al (2005) Multihydroxylated [gd@c82(oh)22]n nanoparticles: Antineoplastic activity of high efficiency and low toxicity. Nano Lett 5(10):2050–2057
Meng H, Xing G, Blanco E, Song Y, Zhao L et al (2012) Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: Imprisoning instead of poisoning cancer cells. Nanomedicine 8(2):136–146
Yin JJ, Lao F, Meng J, Fu PP, Zhao Y et al (2008) Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol 74(4):1132–1140
Meng H, Xing G, Sun B, Zhao F, Lei H et al (2010) Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano 4(5):2773–2783
Yang D, Zhao Y, Guo H, Li Y, Tewary P et al (2010) [gd@c82(oh)22]n nanoparticles induce dendritic cell maturation and activate th1 immune responses. ACS Nano 4(2):1178–1186
Zuo G, Huang Q, Wei G, Zhou R, Fang H (2010) Plugging into proteins: poisoning protein function by a hydrophobic nanoparticle. ACS Nano 4(12):7508–7514
Ge C, Du J, Zhao L, Wang L, Liu Y et al (2011) Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U.S.A. 108(41):16968–16973
Zuo G, Zhou X, Huang Q, Fang HP, Zhou RH (2011) Adsorption of villin headpiece onto graphene, carbon nanotube, and c60: Effect of contacting surface curvatures on binding affinity. J Phys Chem C 115(47):23323–23328
Jacobsen JA, Major Jourden JL, Miller MT, Cohen SM (2010) To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta 1803(1):72–94
Zhao Y, Xing G, Chai Z (2008) Nanotoxicology: are carbon nanotubes safe? Nat Nanotechnol 3(4):191–192
Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311(5761):622–627
Wong-Ekkabut J, Baoukina S, Triampo W, Tang IM, Tieleman DP et al (2008) Computer simulation study of fullerene translocation through lipid membranes. Nat Nanotechnol 3(6):363–368
Qiao R, Roberts AP, Mount AS, Klaine SJ, Ke PC (2007) Translocation of c60 and its derivatives across a lipid bilayer. Nano Lett 7(3):614–619
Shi X, von dem Bussche A, Hurt RH, Kane AB, Gao H (2011) Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat Nanotechnol 6:714–719
Wallace EJ, Sansom MSP (2008) Blocking of carbon nanotube based nanoinjectors by lipids: a simulation study. Nano Lett 8(9):2751–2756
Zhang Y, Ali SF, Dervishi E, Xu Y, Li Z et al (2010) Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived pc12 cells. ACS Nano 4(6):3181–3186
Yang K, Ma YQ (2010) Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat Nanotechnol 5(8):579–583
Vácha R, Martinez-Veracoechea FJ, Frenkel D (2011) Receptor-mediated endocytosis of nanoparticles of various shapes. Nano Lett 11(12):5391–5395
Hu W, Peng C, Luo W, Lv M, Li X et al (2010) Graphene-based antibacterial paper. ACS Nano 4(7):4317–4323
Akhavan O, Ghaderi E (2010) Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 4(10):5731–5736
Liu S, Zeng TH, Hofmann M, Burcombe E, Wei J et al (2011) Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 5(9):6971–6980
Krishnamoorthy K, Veerapandian M, Zhang L-H, Yun K, Kim SJ (2012) Antibacterial efficiency of graphene nanosheets against pathogenic bacteria via lipid peroxidation. J Phys Chem C 116(32):17280–17287
Hu W, Peng C, Lv M, Li X, Zhang Y et al (2011) Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5(5):3693–3700
Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–902
Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3):145–150
Lerf A, He H, Forster M, Klinowski J (1998) Structure of graphite oxide revisited. J Phys Chem B 102(23):4477–4482
Shih CJ, Lin S, Sharma R, Strano MS, Blankschtein D (2012) Understanding the ph-dependent behavior of graphene oxide aqueous solutions: a comparative experimental and molecular dynamics simulation study. Langmuir 28(1):235–241
Medhekar NV, Ramasubramaniam A, Ruoff RS, Shenoy VB (2010) Hydrogen bond networks in graphene oxide composite paper: Structure and mechanical properties. ACS Nano 4(4):2300–2306
Zhao J, Deng B, Lv M, Li J, Zhang Y et al (2013) Graphene oxide-based antibacterial cotton fabrics. Adv Healthc Mater 2013 (in press)
Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358(9276):135–138
Wei C, Lin WY, Zainal Z, Williams NE, Zhu K et al (1994) Bactericidal activity of tio2 photocatalyst in aqueous media: Toward a solar-assisted water disinfection system. Environ Sci Technol 28(5):934–938
Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW et al (2006) Cellular toxicity of carbon-based nanomaterials. Nano Lett 6(6):1121–1125
Schipper ML, Nakayama-Ratchford N, Davis CR, Kam NW, Chu P et al (2008) A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 3(4):216–221
Yu L, Lu Y, Man N, Yu SH, Wen LP (2009) Rare earth oxide nanocrystals induce autophagy in hela cells. Small 5(24):2784–2787
Zhang Q, Yang W, Man N, Zheng F, Shen Y et al (2009) Autophagy-mediated chemosensitization in cancer cells by fullerene c60 nanocrystal. Autophagy 5(8):1107–1117
Zhang Y, Yu C, Huang G, Wang C, Wen L (2010) Nano rare-earth oxides induced size-dependent vacuolization: an independent pathway from autophagy. Int J Nanomed 5:601–609
Wu YN, Yang LX, Shi XY, Li IC, Biazik JM et al (2011) The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. Biomaterials 32(20):4565–4573
Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R et al (2012) Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 41(7):2943–2970
Kundu M, Thompson CB (2008) Autophagy: basic principles and relevance to disease. Annual Rev Pathol 3:427–455
Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27–42
Zabirnyk O, Yezhelyev M, Seleverstov O (2007) Nanoparticles as a novel class of autophagy activators. Autophagy 3(3):278–281
Heath WR, Carbone FR (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47–64
Burgdorf S, Kurts C (2008) Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 20(1):89–95
Vyas JM, Van der Veen AG, Ploegh HL (2008) The known unknowns of antigen processing and presentation. Nat Rev Immunol 8(8):607–618
Guy B (2007) The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5(7):505–517
Marrack P, McKee AS, Munks MW (2009) Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 9(4):287–293
Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776(1):86–107
Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6(7):535–545
Biju V, Itoh T, Anas A, Sujith A, Ishikawa M (2008) Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications. Anal Bioanal Chem 391(7):2469–2495
Chen JY, Lee YM, Zhao D, Mak NK, Wong RN et al (2010) Quantum dot-mediated photoproduction of reactive oxygen species for cancer cell annihilation. Photochem Photobiol 86(2):431–437
Rakovich A, Savateeva D, Rakovich T, Donegan JF, Rakovich YP et al (2010) Cdte quantum dot/dye hybrid system as photosensitizer for photodynamic therapy. Nanoscale Res Lett 5(4):753–760
Choi HS, Liu W, Liu F, Nasr K, Misra P et al (2010) Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 5(1):42–47
Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA (2011) Beating cancer in multiple ways using nanogold. Chem Soc Rev 40(7):3391–3404
Jain PK, Huang X, El-Sayed IH, El-Sayed MA (2008) Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 41(12):1578–1586
Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2(5):681–693
Van de Broek B, Devoogdt N, D’Hollander A, Gijs HL, Jans K et al (2011) Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 5(6):4319–4328
Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H et al (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (pptt) of squamous cell carcinoma in mice. Cancer Lett 269(1):57–66
Lal S, Clare SE, Halas NJ (2008) Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 41(12):1842–1851
Fisher JW, Sarkar S, Buchanan CF, Szot CS, Whitney J et al (2010) Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation. Cancer Res 70(23):9855–9864
Yang K, Zhang S, Zhang G, Sun X, Lee ST et al (2010) Graphene in mice: Ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 10(9):3318–3323
Robinson JT, Tabakman SM, Liang Y, Wang H, Casalongue HS et al (2011) Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 133(17):6825–6831
Huang X, Tang S, Mu X, Dai Y, Chen G et al (2011) Freestanding palladium nanosheets with plasmonic and catalytic properties. Nat Nanotechnol 6(1):28–32
Hessel CM, Pattani VP, Rasch M, Panthani MG, Koo B et al (2011) Copper selenide nanocrystals for photothermal therapy. Nano Lett 11(6):2560–2566
Xie J, Huang J, Li X, Sun S, Chen X (2009) Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 16(10):1278–1294
Xie J, Liu G, Eden HS, Ai H, Chen X (2011) Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 44(10):883–892
Kievit FM, Zhang M (2011) Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 44(10):853–862
Lee J-H, Jang J-T, Choi J-S, Moon SH, Noh S-H et al (2011) Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 6(7):418–422
Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW et al (2012) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12(1):39–50
Venditto VJ, Szoka FC Jr (2013) Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliv Rev 65(1):80–88
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zhou, R. (2015). Nanomedicine: Implications from Nanotoxicity. In: Modeling of Nanotoxicity. Springer, Cham. https://doi.org/10.1007/978-3-319-15382-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-15382-7_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15381-0
Online ISBN: 978-3-319-15382-7
eBook Packages: EngineeringEngineering (R0)